ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2026; 16(3): 165-174


Antifungal potency of Citrus limon essential oil in immunosuppressed Rattus norvegicus with oral candidiasis

Desiana Radithia, Reiska Kumala Bakti, Nisa’a Tassya Fatarnaha, Diah Savitri Ernawati, Adiastuti Endah Parmadiati, Ajiravudh Subarnbhesaj, Bima Ewando Kaban, Winda Dwi Malinda Masuku.



Abstract
Download PDF Post

Oral candidiasis, primarily caused by Candida albicans (C. albicans), is prevalent in immunosuppressed individuals. Prolonged antifungal drug use may contribute to resistance, necessitating alternative therapeutic approaches utilizing natural compounds. Citrus limon (C. limon) essential oil exhibits antifungal activity against C. albicans; thus, this study aimed to assess its efficacy in an immunosuppressed Rattus norvegicus model with oral candidiasis. Immunosuppression was induced using dexamethasone (7.2 mg/kg), followed by oral inoculation with C. albicans. Mice were then assigned to treatment groups receiving C. limon essential oil gel, miconazole gel, or no treatment. After 4 days, untreated mice exhibited significantly more severe tongue lesions than the treated groups. Colony counts confirmed these observations, with hyphal reduction most pronounced in the miconazole group (90%), followed by C. limon (60%) and untreated (40%). Histopathological analysis indicated enhanced macrophage infiltration (5.1 ± 0.738; p < 0.05) and reduced TNF-α expression (1.6 ± 0.516; p < 0.05) in the C. limon -treated group compared to controls. These findings suggest that C. limon essential oil gel may serve as a promising alternative therapy for oral candidiasis in immunosuppressed conditions.

Key words: Oral candidiasis, Candida albicans, immunosuppression, antifungal, Citrus limon, essential oil







Bibliomed Article Statistics

2
R
E
A
D
S

1
D
O
W
N
L
O
A
D
S
02
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.